Watch Ticker

Kyverna Therapeutics, Inc. Common Stock

Go to Kyverna Therapeutics, Inc. Common Stock Website

$3.41

0.00 (0.00%)

Live

Previous Close

$3.41

Day Range

$0 - $0

Previous Day Range

$3.31 - $3.49

Market Cap

$145.6 million USD

Day Vol.

Previous Day Vol.

190798

Currency

USD

Primary Exchange

None

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Grabar Law Office - Notice to Long-Term Shareholders of Archer-Daniels-Midland Co. (NYSE: ADM); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Kyverna Therapeutics, Inc. (Nasdaq: KYTX); and Mercury Systems, Inc. (Nasdaq: MRCY): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office is investigating claims on behalf of long-term shareholders of Archer-Daniels-Midland, Driven Brands, Kyverna Therapeutics, and Mercury Systems, as their respective securities fraud class action complaints have survived motions to dismiss.

Related tickers: ADM, DRVN, KYTX, MRCY.

Read Full Article

Grabar Law Office - Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

Grabar Law Office is investigating claims on behalf of shareholders of Fluence Energy, Kyverna Therapeutics, Mercury Systems, and Sage Therapeutics, alleging breaches of fiduciary duties by certain officers and directors.

Related tickers: FLNC, KYTX, MRCY, SAGE.

Read Full Article

Trending Tickers

Please sign in to view